Curis (CRIS) Cash & Equivalents (2010 - 2026)

Curis (CRIS) has 17 years of Cash & Equivalents data on file, last reported at $15.0 million in Q1 2026.

• Quarterly Cash & Equivalents fell 26.04% year-over-year to $15.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.0 million (down 26.04% YoY) and the FY2025 annual result came in at $5.1 million, down 74.69% from the prior year.
• Cash & Equivalents grew to $15.0 million in Q1 2026, from $5.1 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $34.0 million in Q2 2022 to a low of $5.1 million in Q4 2025.
• A 5-year average of $20.3 million and a median of $20.0 million in 2024 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents sank 83.37% — and 2023, when it jumped 71.63%.
• Tracing CRIS's Cash & Equivalents over 5 years: stood at $19.7 million in 2022, then jumped by 35.73% to $26.7 million in 2023, then retreated by 25.05% to $20.0 million in 2024, then tumbled by 74.69% to $5.1 million in 2025, then surged by 196.4% to $15.0 million in 2026.
• The last three Cash & Equivalents figures came in at $15.0 million (Q1 2026), $5.1 million (Q4 2025), and $9.1 million (Q3 2025), per Business Quant data.